DEA Extends Emergency Ban on Fake MarijuanaBy Phillip Smith March 1, 2012
WASHINGTON, DC — The DEA has extended for another six months its emergency ban on five synthetic cannabinoids used to manufacture “fake weed” products. The chemicals are sprayed on herbal mixtures and the resulting product is sold under names including Spice and K2.
The agency first enacted the ban a year ago, but that emergency ban was set to expire today. The DEA published the extension in the federal register today.
The extension continues the ban on five synthetic cannabinoids: JWH-018, JWH-073, JWH-200, CP-47,497 (that’s all one chemical CP-47,497) and cannabicyclohexanol. The ban means those substances are treated as Schedule I drugs under federal law.
“Schedule 1 substances are reserved for those substances with a high potential for abuse, no currently accepted medical use in treatment in the United States and a lack of accepted safety for use of the drug under medical supervision,” the DEA reminded in a Wednesday press release.
The American Association of Poison Control Centers reported last month that after synthetic marijuana products first appeared on their radar in 2009, generating several hundred calls, the number jumped to 2,906 calls in 2010 and 6,956 last year. Their data also showed that the number of calls peaked in July 2011 at 705 and have declined since then, with 551 calls reported in December.
The poison centers and emergency room doctors have reported such symptoms as disorientation, elevated heart rates, and vomiting, similar to those reported from adverse reactions to marijuana. There are no confirmed reports of overdose deaths, and only a handful of deaths potentially linked to synthetic marijuana, including a trio of suicides after use, a young man killed in a traffic accident while driving after use, and a 13-year-old Pennsylvania boy who smoked synthetic weed out of a plastic Pez dispenser and later died of complications from a lung transplant.
“We continue to address the problems of synthetic drug manufacturing, trafficking, and abuse. Our efforts have clearly shown that these chemicals present an imminent threat to public safety,” said DEA Administrator Michele M. Leonhart. “This six month extension is critical and gives us the time necessary to conduct the administrative scheduling process for permanent control.
A number of states have and localities have already banned synthetic marijuana, and more are moving to do so this year. Federal legislation that would ban both synthetic marijuana and new synthetic stimulants (“bath salts”) has passed the House, but is being blocked in the Senate by a hold placed on it by Sen. Rand Paul (R-KY).
This week, the Drug Policy Alliance (DPA) joined the American Civil Liberties Union, NAACP and more than 30 other organizations on a letter to members of the Senate urging them to oppose the legislation. In a separate press release, DPA urged Congress to not just reject the synthetic drug legislation but also overhaul US drug policy, pointing out that last year marked the 40th Anniversary of President Nixon declaring a war on drugs, and despite the government arresting tens of millions of nonviolent Americans and spending more than a trillion dollars, drugs are cheap, potent, and readily available in every community.
“Senator Rand Paul is standing up to both political parties and doing what it takes to protect Kentucky taxpayers from the career politicians in Washington who want to waste more money on failed drug policies,” said Bill Piper, DPA director of national affairs. “He should be applauded for opposing government waste and supporting public safety. The failed war on drugs costs too much and achieves too little; it is time for a new approach.”